Prof. Philippe Backeljauw
Professor of Clinical Pediatrics
- Cincinnati Children’s Hospital Medical Center
United States
Prof. Philippe Backeljauw has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Prof. Philippe Backeljauw is a consultant for Novo Nordisk, Novartis/Sandoz, Tolmar Pharmaceuticals, Ascendis Pharma, BioMarin Pharmaceutical, Cavalry Biosciences and Ipsen, and currently receives research support from Novo Nordisk, Novartis and Ipsen
Programmes developed by Prof. Philippe Backeljauw
Video podcast
Episode
1
of 2
Pediatrics Endocrinology Rare diseases
Short stature: Key challenges in diagnosis and management – Episode 1
Video podcast exploring primary IGF-I deficiency, GH deficiency and other rare growth disorders
Experts
Prof. Dr. Joachim Woelfle, Prof. Philippe BackeljauwEndorsed by
-
Downloadable
Resources -
MIN
-
Dec 2023
Micro learning - Video, slides and more
Rare diseases Pediatrics Endocrinology
Recognising and Diagnosing Severe Primary IGF-I Deficiency (SPIGFD)
A micro learning programme from paediatric endocrinologists
Experts
Prof. Philippe Backeljauw, Prof. Peter BangEndorsed by
-
Downloadable
Resources -
MIN
-
Feb 2023
